TY - JOUR A1 - Liaqat, Anam A1 - Sednev, Maksim V. A1 - Stiller, Carina A1 - Höbartner, Claudia T1 - RNA-cleaving deoxyribozymes differentiate methylated cytidine isomers in RNA JF - Angewandte Chemie International Edition N2 - Deoxyribozymes are emerging as modification-specific endonucleases for the analysis of epigenetic RNA modifications. Here, we report RNA-cleaving deoxyribozymes that differentially respond to the presence of natural methylated cytidines, 3-methylcytidine (m\(^3\)C), N\(^4\)-methylcytidine (m\(^4\)C), and 5-methylcytidine (m\(^5\)C), respectively. Using in vitro selection, we found several DNA catalysts, which are selectively activated by only one of the three cytidine isomers, and display 10- to 30-fold accelerated cleavage of their target m\(^3\)C-, m\(^4\)C- or m\(^5\)C-modified RNA. An additional deoxyribozyme is strongly inhibited by any of the three methylcytidines, but effectively cleaves unmodified RNA. The mXC-detecting deoxyribozymes are programmable for the interrogation of natural RNAs of interest, as demonstrated for human mitochondrial tRNAs containing known m\(^3\)C and m\(^5\)C sites. The results underline the potential of synthetic functional DNA to shape highly selective active sites. KW - organic chemistry KW - site-specific RNA cleavage KW - deoxyribozymes KW - epitranscriptomics KW - in vitro selection KW - RNA modification Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-256519 VL - 60 ER - TY - JOUR A1 - Kabinger, Florian A1 - Stiller, Carina A1 - Schmitzová, Jana A1 - Dienemann, Christian A1 - Kokic, Goran A1 - Hillen, Hauke S. A1 - Höbartner, Claudia A1 - Cramer, Patrick T1 - Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis JF - Nature Structural & Molecular Biology N2 - Molnupiravir is an orally available antiviral drug candidate currently in phase III trials for the treatment of patients with COVID-19. Molnupiravir increases the frequency of viral RNA mutations and impairs SARS-CoV-2 replication in animal models and in humans. Here, we establish the molecular mechanisms underlying molnupiravir-induced RNA mutagenesis by the viral RNA-dependent RNA polymerase (RdRp). Biochemical assays show that the RdRp uses the active form of molnupiravir, β-d-\(N^4\)-hydroxycytidine (NHC) triphosphate, as a substrate instead of cytidine triphosphate or uridine triphosphate. When the RdRp uses the resulting RNA as a template, NHC directs incorporation of either G or A, leading to mutated RNA products. Structural analysis of RdRp–RNA complexes that contain mutagenesis products shows that NHC can form stable base pairs with either G or A in the RdRp active center, explaining how the polymerase escapes proofreading and synthesizes mutated RNA. This two-step mutagenesis mechanism probably applies to various viral polymerases and can explain the broad-spectrum antiviral activity of molnupiravir. KW - Molnupiravir KW - RNA-Dependent RNA Polymerase KW - SARS-CoV2 Replication Impairment KW - Molnupiravir-Induced RNA Mutagenesis Mechanism KW - Cryoelectron Microscopy Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-254603 VL - 28 ER - TY - JOUR A1 - Liaqat, Anam A1 - Sednev, Maksim V. A1 - Stiller, Carina A1 - Höbartner, Claudia T1 - RNA-Cleaving Deoxyribozymes Differentiate Methylated Cytidine Isomers in RNA JF - Angewandte Chemie International Edition N2 - Deoxyribozymes are emerging as modification-specific endonucleases for the analysis of epigenetic RNA modifications. Here, we report RNA-cleaving deoxyribozymes that differentially respond to the presence of natural methylated cytidines, 3-methylcytidine (m\(^3\)C), N\(^4\)-methylcytidine (m\(^4\)C), and 5-methylcytidine (m\(^5\)C), respectively. Using in vitro selection, we found several DNA catalysts, which are selectively activated by only one of the three cytidine isomers, and display 10- to 30-fold accelerated cleavage of their target m\(^3\)C-, m\(^4\)C- or m\(^5\)C-modified RNA. An additional deoxyribozyme is strongly inhibited by any of the three methylcytidines, but effectively cleaves unmodified RNA. The m\(^X\)C-detecting deoxyribozymes are programmable for the interrogation of natural RNAs of interest, as demonstrated for human mitochondrial tRNAs containing known m\(^3\)C and m\(^5\)C sites. The results underline the potential of synthetic functional DNA to shape highly selective active sites. KW - Deoxyribozymes KW - Epitranscriptomics KW - RNA Modification KW - Site-Specific RNA Cleavage KW - in vitro Selection Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-254544 VL - 60 IS - 35 ER -